BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,927 | -22.7% | 687 | -6.7% | 0.02% | -25.0% |
Q2 2023 | $33,532 | +12.3% | 736 | 0.0% | 0.02% | +11.1% |
Q1 2023 | $29,852 | -14.7% | 736 | +7.1% | 0.02% | -18.2% |
Q4 2022 | $35,016 | -5.4% | 687 | 0.0% | 0.02% | -12.0% |
Q3 2022 | $37,000 | -15.9% | 687 | 0.0% | 0.02% | -10.7% |
Q2 2022 | $44,000 | -17.0% | 687 | 0.0% | 0.03% | -6.7% |
Q1 2022 | $53,000 | -10.2% | 687 | 0.0% | 0.03% | -6.2% |
Q4 2021 | $59,000 | +7.3% | 687 | 0.0% | 0.03% | -3.0% |
Q3 2021 | $55,000 | -9.8% | 687 | -9.2% | 0.03% | -13.2% |
Q2 2021 | $61,000 | -7.6% | 757 | -3.8% | 0.04% | -17.4% |
Q1 2021 | $66,000 | +4.8% | 787 | 0.0% | 0.05% | -4.2% |
Q4 2020 | $63,000 | +26.0% | 787 | +28.0% | 0.05% | +14.3% |
Q3 2020 | $50,000 | -5.7% | 615 | 0.0% | 0.04% | -10.6% |
Q2 2020 | $53,000 | +6.0% | 615 | 0.0% | 0.05% | -13.0% |
Q1 2020 | $50,000 | -2.0% | 615 | 0.0% | 0.05% | +25.6% |
Q4 2019 | $51,000 | -5.6% | 615 | 0.0% | 0.04% | -14.0% |
Q3 2019 | $54,000 | +8.0% | 615 | 0.0% | 0.05% | +16.3% |
Q2 2019 | $50,000 | -5.7% | 615 | -4.9% | 0.04% | +59.3% |
Q1 2019 | $53,000 | +381.8% | 647 | +276.2% | 0.03% | +285.7% |
Q4 2018 | $11,000 | -15.4% | 172 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $13,000 | -53.6% | 172 | -55.0% | 0.01% | -56.2% |
Q2 2018 | $28,000 | -89.4% | 382 | -90.6% | 0.02% | -89.7% |
Q1 2018 | $265,000 | +4.3% | 4,062 | +3.6% | 0.16% | +2.0% |
Q4 2017 | $254,000 | – | 3,921 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |